BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8198334)

  • 1. Increased incidence of thyroid cancer in patients with primary hyperparathyroidism: a continuing dilemma.
    Fedorak IJ; Salti G; Fulton N; Schark C; Straus FH; Kaplan EL
    Am Surg; 1994 Jun; 60(6):427-31. PubMed ID: 8198334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in size.
    McCoy KL; Jabbour N; Ogilvie JB; Ohori NP; Carty SE; Yim JH
    Surgery; 2007 Dec; 142(6):837-44; discussion 844.e1-3. PubMed ID: 18063065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normocalcemic, subclinical, asymptomatic primary hyperparathyroidism in patients with goiter or papillary thyroid cancer--preliminary report. Normocalcemic primary hyperparathyroidism and thyroid pathology.
    Niedźwiecki S; Kuzdak K; Kaczka K; Pomorski L
    Wiad Lek; 2007; 60(5-6):228-30. PubMed ID: 17966885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Simultaneous interventions of the thyroid gland in primary hyperparathyroidism (pHPT)].
    Friedrich J; Krause U; Olbricht T; Eigler FW
    Zentralbl Chir; 1995; 120(1):43-6. PubMed ID: 7887038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of malignancy within cytologically indeterminate thyroid nodules.
    Miller B; Burkey S; Lindberg G; Snyder WH; Nwariaku FE
    Am J Surg; 2004 Nov; 188(5):459-62. PubMed ID: 15546550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is preoperative investigation of the thyroid justified in patients undergoing parathyroidectomy for hyperparathyroidism?
    Bentrem DJ; Angelos P; Talamonti MS; Nayar R
    Thyroid; 2002 Dec; 12(12):1109-12. PubMed ID: 12593724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Trends of thyroid pathology in a referral center: steady prevalence of papillary thyroid carcinoma but goiter increase in thyroidectomies].
    Gamboa-Domínguez A; Lino-Silva S; Candanedo-González F; Medina-López E; Acuña-González D; Jacinto-Cortés I; González-Treviño O
    Rev Invest Clin; 2011; 63(2):148-54. PubMed ID: 21717721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of primary hyperparathyroidism and non-medullary thyroid cancer.
    Krause UC; Friedrich JH; Olbricht T; Metz K
    Eur J Surg; 1996 Sep; 162(9):685-9. PubMed ID: 8908448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population.
    Uchino S; Noguchi S; Kawamoto H; Yamashita H; Watanabe S; Yamashita H; Shuto S
    World J Surg; 2002 Aug; 26(8):897-902. PubMed ID: 11965446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
    Furlan JC; Bedard YC; Rosen IB
    J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differentiated thyroid gland carcinomas in "autonomous adenomas" in childhood].
    Müller A; Goretzki P; Witte J; Gerharz P; Röher HD
    Chirurg; 1995 Oct; 66(10):1018-20. PubMed ID: 8529444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thyroid carcinoma. Retrospective analysis of case records of the III. Surgery Department at the Umberto I Clinics in Rome in the years 1990-93].
    Picchi P; Salabè GB; Marzullo A; Faloci C; Campana FP
    Minerva Endocrinol; 1996 Dec; 21(4):115-21. PubMed ID: 9132562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
    Gemsenjäger E; Heitz PU; Martina B; Schweizer I
    Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Coincidence of non-medullary thyroid cancer and hyperparathyroidism].
    Krause U; Olbricht T; Metz K; Rudy T; Benker G
    Chirurg; 1991 Jul; 62(7):536-9. PubMed ID: 1935379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexisting thyroid and parathyroid disease--are they related?
    Lever EG; Refetoff S; Straus FH; Nguyen M; Kaplan EL
    Surgery; 1983 Dec; 94(6):893-900. PubMed ID: 6648801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective analysis of thyroid cancer.
    Ertürk E; Tuncel E; Yerci O; Gürsoy N; Imamoğlu S; Koran N; Arinik A
    J Environ Pathol Toxicol Oncol; 1996; 15(2-4):245-9. PubMed ID: 9216815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. History of thyroid diseases and subsequent thyroid cancer risk.
    D'Avanzo B; La Vecchia C; Franceschi S; Negri E; Talamini R
    Cancer Epidemiol Biomarkers Prev; 1995; 4(3):193-9. PubMed ID: 7606193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and management of incidental thyroid nodules in patients with another primary malignancy.
    Wilhelm SM; Robinson AV; Krishnamurthi SS; Reynolds HL
    Surgery; 2007 Oct; 142(4):581-6; discussion 586-7. PubMed ID: 17950351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Well-differentiated thyroid carcinoma: factors predicting recurrence and survival.
    Lim LH; Soo KC; Chong YK; Gao F; Hong GS; Lim TH
    Singapore Med J; 2002 Sep; 43(9):457-62. PubMed ID: 12568423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.